<DOC>
	<DOCNO>NCT00026273</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug give surgery may kill tumor cell . PURPOSE : Randomized phase III trial compare effectiveness fluorouracil leucovorin without irinotecan treating patient undergone surgery stage III colorectal cancer .</brief_summary>
	<brief_title>Fluorouracil Leucovorin With Without Irinotecan Treating Patients Following Surgery Stage III Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare disease-free survival 3 year patient resect stage III colorectal cancer treat adjuvant fluorouracil leucovorin calcium without irinotecan . - Compare disease-free overall survival 5 year patient treat regimen . - Compare safety profile treatment regimens patient . - Compare quality-adjusted survival patient treat regimen . - Correlate expression putative prognostic marker ( thymidylate synthase , telomerase , topoisomerase ) disease-free overall survival patient treat regimen . OUTLINE : This randomize , open-label , multicenter study . Patients stratify accord participate center . Patients randomize 1 2 treatment arm . Arm I - Patients receive irinotecan IV 30-90 minute , leucovorin calcium IV 2 hour , fluorouracil IV 24 hour weekly 6 week . Courses repeat every 7 week 4 course absence disease progression unacceptable toxicity . - As alternative schedule , patient may receive irinotecan IV 30-90 minute day 1 leucovorin calcium IV 2 hour fluorouracil IV 22 hour day 1 2 every 2 week 6 week . Treatment repeat every 6 week 4 course absence disease progression unacceptable toxicity . Arm II - Patients receive leucovorin calcium fluorouracil arm I . Quality life may assess baseline ; prior course 2 , 3 , 4 ; 1 , 3 , 6 month . Patients follow every 3 month 3 year every 6 month 2 year . PROJECTED ACCRUAL : Approximately 1800 patient ( 900 per arm ) accrue study within 24 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma colon intraperitoneal rectum Stage III Completely resect within past 38 week No gross microscopic evidence residual disease surgery No rectal cancer require total mesorectal resection pre postoperative radiotherapy No prior curatively resect synchronous metastasis colorectal cancer PATIENT CHARACTERISTICS : Age : 18 75 Performance status : WHO 01 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 2,000/mm^3 Platelet count least 150,000/mm^3 Hemoglobin least 10 g/dL Hepatic : Bilirubin great upper limit normal ( ULN ) AST ALT great 2.5 time ULN Alkaline phosphatase great 2.5 time ULN Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 60 mL/min Cardiovascular : No myocardial infarction past year No uncontrolled hypertension No highrisk uncontrolled arrhythmia No unstable angina pectoris Other : HIV negative No chronic diarrhea No current chronic inflammation subobstruction bowel surgery No active uncontrolled infection No prior concurrent malignancy except curatively treat nonmelanoma skin cancer carcinoma situ cervix No psychological , social , familial , geographical condition would preclude followup Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 6 month study participation PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior antineoplastic chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics No prior celioscopic resection primary tumor Other : At least 30 day since prior participation another clinical trial investigational drug No concurrent experimental drug No concurrent anticancer therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>